1. Adams, C. P., & Brantner, V. V. (2010). Spending on new drug development. Health Economics, 19(2), 130–141.
2. Amgen. (2012). Biologics and biosimilars: An overview. Online posting. Available at: http://www.amgen.com/pdfs/misc/Biologics_and_Biosimilars_Overview.pdf
3. Attaran, A., & Bate, R. (2012). Deadly fake medicines. New York Times, 20 Nov 2012. Available at: https://www.nytimes.com/2012/11/21/opinion/deadly-fake-medicines.html.
4. Battelle. (2015). Biopharmaceutical industry-sponsored clinical trials: Impact on state economies, March 2015. Available at: http://www.phrma.org/sites/default/files/pdf/biopharmaceutical-industry-sponsored-clinical-trials-impact-on-state-economies.pdf
5. Biotechnology Industry Organization (BIO). (2010). How do drugs and biologics differ? online posting, 10 Nov 2010.